118 related articles for article (PubMed ID: 2493565)
1. Cerebrotendinous xanthomatosis.
Berginer VM; Salen G; Shefer S
Neurol Clin; 1989 Feb; 7(1):55-74. PubMed ID: 2493565
[TBL] [Abstract][Full Text] [Related]
2. [Cerebrotendinous xanthomatosis].
Berginer VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):13-22. PubMed ID: 1333699
[TBL] [Abstract][Full Text] [Related]
3. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
4. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
Salen G; Grundy SM
J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
[TBL] [Abstract][Full Text] [Related]
6. [Cerebrotendinous xanthomatosis].
Baumgartner RW; Hauser V; Grob P; Waespe W
Schweiz Med Wochenschr; 1991 Jun; 121(23):858-64. PubMed ID: 1857943
[TBL] [Abstract][Full Text] [Related]
7. Cerebrotendinous xanthomatosis.
Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
[TBL] [Abstract][Full Text] [Related]
8. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
[TBL] [Abstract][Full Text] [Related]
9. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
[TBL] [Abstract][Full Text] [Related]
10. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
[TBL] [Abstract][Full Text] [Related]
11. [Cerebrotendinous xanthomatosis: report of 4 patients].
Ferrándiz-Pulido C; Bartralot R; Girós M; Bassas P; Heras C; Bodet D; Savall R; García-Patos V
Actas Dermosifiliogr; 2009 Apr; 100(3):222-6. PubMed ID: 19457308
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
Berginer VM; Foster NL; Sadowsky M; Townsend JA; Siegel GJ; Salen G
Am J Psychiatry; 1988 Mar; 145(3):354-7. PubMed ID: 3344851
[TBL] [Abstract][Full Text] [Related]
13. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
Preiss Y; Santos JL; Smalley SV; Maiz A
Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
[TBL] [Abstract][Full Text] [Related]
14. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
Björkhem I; Hansson M
Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
[TBL] [Abstract][Full Text] [Related]
15. [Cerebrotendinous xanthomatosis: utility of nuclear magnetic resonance image in the follow-up and response to treatment].
Cuende E; Gómez-Rz de Mendarozqueta M; Vesga JC; Saracíbar N; Ibáñez-Avilés A; Castellano-Hurtado C
Rev Neurol; 1996 Dec; 24(136):1535-8. PubMed ID: 9064170
[TBL] [Abstract][Full Text] [Related]
16. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
[TBL] [Abstract][Full Text] [Related]
17. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.
Nie S; Chen G; Cao X; Zhang Y
Orphanet J Rare Dis; 2014 Nov; 9():179. PubMed ID: 25424010
[TBL] [Abstract][Full Text] [Related]
18. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
Björkhem I; Buchmann MS; Skrede S
Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
[TBL] [Abstract][Full Text] [Related]
19. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
Moghadasian MH
Clin Invest Med; 2004 Feb; 27(1):42-50. PubMed ID: 15061585
[TBL] [Abstract][Full Text] [Related]
20. [Cerebrotendinous xanthomatosis and phytosterolemia].
Nakamura T; Matsuzawa Y
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):794-7. PubMed ID: 3152095
[No Abstract] [Full Text] [Related]
[Next] [New Search]
